NCT03574805View on ClinicalTrials.gov

Study of Multiple Doses of PRS-060 Administered by Oral Inhalation in Subjects With Mild Asthma

PHASE1CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

June 26, 2018

Primary Completion Date

September 15, 2020

Study Completion Date

September 15, 2020

Conditions
Asthma
Interventions
DRUG

PRS-060

Study drug

DRUG

Placebo

Inhalant designed to mimic PRS-060

Trial Locations (4)

3004

Nucleus Network Limited, Melbourne

4006

Q-Pharm, Herston

5000

CMAX, Adelaide

6009

Linear, Nedlands

All Listed Sponsors
lead

Pieris Australia Pty Ltd

INDUSTRY

NCT03574805 - Study of Multiple Doses of PRS-060 Administered by Oral Inhalation in Subjects With Mild Asthma | Biotech Hunter | Biotech Hunter